Even when the UK decided to reduce the gap between the first and second doses of Covishield to eight weeks, the government upheld that decision. The government has stated that a single dose of the vaccine is 60-85% effective in preventing the disease (in mild, moderate and severe cases) and inhibits transmission, according to a group of vaccine experts.
Authorities said the government would study the rationale for the decision made by Britain, moving the interval back to eight weeks. The Center said the UK’s experience based on actual vaccination rather than limited research is the basis of India’s decision to increase the interval from 6-8 weeks to 12-16 weeks.
“They make decisions based on their situation, mutants, pandemiology … we took it according to risk epidemiology. We are driven by science. This is dynamic. It’s a process, “said NITIA ayog, Dr. VK Paul of Member Health.
“If science changes tomorrow, we will move forward accordingly,” said Dr. Paul. The UK on Friday reversed the gap between the first and second doses of Covishield for all clinically vulnerable people over the age of 50 to 12 to 8 weeks. It cited concerns about the first detected B.1.617 variant in India behind that decision.
Dr. Paul also argued that the decision to increase the time interval between the two doses of Covishield vaccine was made under some pressure or due to a lack of vaccine. “Independent scientists at our institute made these decisions after studying the data to reduce the risk of infection in the Indian population,” said Dr. Paul of the National Technical Advisory Group on Immunization. Said referring to the recommendations. TNN
Government, Health News, ET HealthWorld
Source link Government, Health News, ET HealthWorld